Richard A. Miller - Jun 2, 2022 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
President and CEO, Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller
Stock symbol
CRVS
Transactions as of
Jun 2, 2022
Transactions value $
$5,797
Form type
4
Date filed
6/6/2022, 06:43 PM
Previous filing
Apr 1, 2022
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVS Common Stock Purchase $4.73K +4.83K +0.36% $0.98 1.34M Jun 2, 2022 By Trust F1
transaction CRVS Common Stock Purchase $165 +170 +0.01% $0.97 1.34M Jun 2, 2022 By Trust F1
transaction CRVS Common Stock Purchase $899 +890 +0.07% $1.01 1.34M Jun 6, 2022 By Trust F1
holding CRVS Common Stock 35.7K Jun 2, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.